3Wilke HJ,Van Cutsem E.Current treatments and future perspectives in colorectal and gastric cancer.Ann Oncol,2003,14(2):49-55.
4de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer[J]. J Clin Oncol, 2000, 18(16): 2938- 2947.
5Giacchetti S, Perpoint B, Zidani R, et al. Phase IlI multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer[J]. J Clin Oncol, 2000, 18(1): 136-147.
6Douillard JY, Cunningbam D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial[J]. Lancet, 2000, 355(9209): 1041-1047.
7Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer[J]. N Engl J Med, 2005, 352: 476-487.
8Cassidy J, Clarke S, Diaz-Rubio E, et al. Randomized phase HI study of capecitabine plus oxaliplatin compared with fluorouracil/fblinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer[J]. J Clin Oncol, 2008,26(12): 2006-2012.
9Diaz-Rubio E, Tabemero J, Gomez-Espana A, et al. Phase HI study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic eolorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial[J]. J Clin Oncol, 2007, 25(27): 4224-4230.
10Ohtsu A, Baba H, Sakata Y, et al. Phase Ⅱ study of S-l, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinoma.[J]. Br J Cancer, 2000, 83(2): 141-145.
